AiCure Introduces Computer Vision Platform To Remotely Capture Digital Biomarkers In Clinical Trials

On April 28, 2020, AiCure, an AI and advanced data analytics company, announced the launch of its digital biomarker platform to remotely detect subtle changes in an individual's condition. The platform leverages computer vision and artificial intelligence to gather and analyze visual and auditory cues directly through the consumer's smartphone camera, pinpointing critical responses and behavioral trends with the frequency and accuracy needed to elevate the integrity of clinical trial data. By aggregating clinically-sound insights in an individual's natural environment, AiCure empowers pharmaceutical companies to improve their understanding of disease symptomology, drug dosing side effects, and . . .